AstraZeneca PLC

AZN Makes Notable Cross Below Critical Moving Average

11 Mar 2025 11:58:07 By NASDAQ US Markets

AZN : Imfinzi Improves Event-Free Survival In Early-Stage Gastric & GEJ Cancers In Phase III Trial

07 Mar 2025 02:51:13 By NASDAQ US Markets

AZN: TEZSPIRE Reduces Nasal Polyp Severity And Surgery Need In CRSwNP Patients In Phase III Trial

01 Mar 2025 21:14:04 By NASDAQ US Markets

AstraZeneca's Camizestrant Shows Positive Interim Results In SERENA-6 Phase 3 Trial

26 Feb 2025 02:43:24 By NASDAQ US Markets

FibroGen Announces Sale of China Subsidiary to AstraZeneca for Approximately $160 Million

20 Feb 2025 07:51:49 By NASDAQ Stocks

Ex-Dividend Reminder: Vestis Corp, ONE Gas and AstraZeneca

19 Feb 2025 10:26:27 By NASDAQ US Markets

Ex-Dividend Reminder: Vestis Corp, ONE Gas and AstraZeneca

19 Feb 2025 10:06:54 By NASDAQ Stocks

2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025

15 Feb 2025 09:07:29 By NASDAQ US Markets

AZN April 4th Options Begin Trading

13 Feb 2025 12:18:24 By NASDAQ US Markets

Why AstraZeneca Topped the Market on Thursday

06 Feb 2025 17:24:24 By NASDAQ US Markets

AstraZeneca Plc (AZN) Q4 2024 Earnings Call Transcript

06 Feb 2025 14:13:48 By NASDAQ US Markets

Nasdaq 100 Movers: ARM, AZN

06 Feb 2025 10:38:48 By NASDAQ US Markets

AstraZeneca: CHMP Recommends Approval Of Imfinzi In The EU

03 Feb 2025 02:58:39 By NASDAQ US Markets

Interesting AZN Put And Call Options For March 14th

30 Jan 2025 11:09:34 By NASDAQ US Markets

FDA Approves AstraZeneca And Daiichi Sankyo's ENHERTU For HER2-Low/Ultralow Breast Cancer

27 Jan 2025 20:00:56 By NASDAQ US Markets

InnovationRx: The Impact Of Trump’s Withdrawal From The WHO And His Other Healthcare Orders

22 Jan 2025 13:41:38 By Forbes - World

FDA Okays AstraZeneca And Daiichi's Datroway For Metastatic HR-Positive, HER2-Negative Breast Cancer

18 Jan 2025 01:34:04 By NASDAQ US Markets

Better Buy: Novo Nordisk vs. AstraZeneca

04 Jan 2025 06:11:10 By NASDAQ US Markets

Syncona: Achilles Announces Sale Of Technology Assets To AstraZeneca - Quick Facts

27 Dec 2024 02:32:04 By NASDAQ US Markets

AstraZeneca And Daiichi Sankyo Withdraw EU Marketing Application For Datopotamab Deruxtecan

24 Dec 2024 02:40:25 By NASDAQ US Markets